Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia

BACKGROUND: The World Health Organization (WHO) strongly suggests using corticosteroids in patients with severe coronavirus disease 2019 (COVID-19). Similarly, a large randomized controlled clinical trial (RCT) in the UK found that dexamethasone effectively reduced the mortality rate in severe COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zheng, Shi, Fang, Liu, Jun-Xia, Liu, Jia-Qi, Li, Jing, Wang, Qian, Wang, Hui, Gao, Chang-Lan, Li, Jian-Min, Zhao, Dong-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285565/
https://www.ncbi.nlm.nih.gov/pubmed/34285519
http://dx.doi.org/10.2147/IDR.S314938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285565/
https://www.ncbi.nlm.nih.gov/pubmed/34285519
http://dx.doi.org/10.2147/IDR.S314938

Ejemplares similares